Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma
Authors:
- 1 March 2015
- journal article
- Published by Elsevier in Molecular Cell
- Vol. 57 (5) , 784-796
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with VemurafenibNew England Journal of Medicine, 2012
- Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring V600EBRAFOncogene, 2011
- STAT3 Mediates Resistance to MEK Inhibitor through MicroRNA miR-17Cancer Research, 2011
- PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM ExpressionCancer Research, 2011
- Regulation of the Apaf-1–caspase-9 apoptosomeJournal of Cell Science, 2010
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAFNature, 2010
- V600E BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathwayProceedings of the National Academy of Sciences, 2009